GCC
CLB icon

Guardian Capital (Canada)’s Core Laboratories CLB Stock Holding History

Guardian Capital (Canada)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,168
Closed -$638K – 166
2021
Q1 		$638K Buy
+22,168
New +$757K 0.01% 147

Other funds holding CLB

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Guardian Capital (Canada)'s CLB Position: Q2 2021 in Review

Guardian Capital (Canada) sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 22,168 shares — an estimated $638K sold.

Guardian Capital (Canada) first reported a position in CLB in Q1 2021 and held it in 1 quarter. The position peaked at $638K in Q1 2021. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Guardian Capital (Canada) reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Guardian Capital (Canada) sold 22,168 Core Laboratories shares in Q2 2021, an estimated $638K.
  • Guardian Capital (Canada) first reported a position in Core Laboratories in Q1 2021 and held it in 1 quarter.
  • Guardian Capital (Canada)'s Core Laboratories position peaked at $638K in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2021, filed 17 Aug 2021.